Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCastelnau Group Regulatory News (CGL)

Share Price Information for Castelnau Group (CGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 78.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (3.896%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 78.50
CGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nil Paid Rights

26 Mar 2009 07:02

RNS Number : 5134P
Catlin Group Limited
26 March 2009
 



This announcement is not for publication or distribution, directly or indirectly, in or into the United StatesCanadaAustraliaNew ZealandJapanSouth Africa or any other jurisdiction in which the same would be unlawful

Catlin Group Limited Results of Rights Issue

Catlin Group Limited ('Catlin') today announces that under the terms of a 2 for 5 Rights Issue announced on 12 February 2009, valid acceptances have been received in respect of 98.68 per cent. of the total number of New Common Shares offered to Shareholders.

The Rights Issue was fully underwritten by J.P. Morgan Securities Ltd. on behalf of J.P. Morgan Cazenove and UBS Limited.

As disclosed on page 48 of the prospectus relating to the Rights Issue, J.P. Morgan Cazenove and UBS Limited, acting as Joint Bookrunners, will use reasonable endeavours to procure acquirers for the balance of New Common Shares not validly taken up in the Rights Issue. A further announcement as to the number of New Common Shares for which acquirers have been procured will be made in due course.

For more information contact:

Catlin Group Limited

Media Relations:

James Burcke, Head of Communications

Tel: +44 (0)20 7458 5710

Mobile+44 (0)7958 767 738

Investor Relations:

William Spurgin, Head of Investor Relations

Tel: +44 (0)20 7458 5726

Mobile+44 (0)7710 314 365

Maitland PR Adviser

Liz Morley

Tel: +44 (0)20 7379 5151

J.P. Morgan Cazenove

Sponsor, Joint Broker and Joint Bookrunner

Conor Hillery

Laurence Hollingworth

Mike Collar

Tel: +44 (0)20 7588 2828

UBS Limited

Joint Broker and Joint Bookrunner

Phillip Shelley

Anna Swire

Tel: +44 (0)20 7567 8000

  Definitions used in the prospectus relating to the Rights Issue dated 12 February 2009 shall have the same meaning when used in this announcement, unless the context requires otherwise.

This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Nil Paid Rights, New Common Shares or New Depositary Interests and shall not form the basis of, or be relied upon in connection with, any contract to purchase or subscribe for any Nil Paid Rights, New Common Shares or New Depository Interests. Past performance is no guide to future performance and any investment decision to take up or buy Nil Paid Rights, New Common Shares or (in the case of Depositary Interest Holders only) New Depositary Interests must be made solely on the basis of publicly available information. Persons needing advice should consult an independent financial adviser.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States, Canada, Australia, New Zealand, Japan, South Africa or any jurisdiction in which the same would be unlawful. This announcement is for information only and does not constitute an offer or invitation to take up, acquire or dispose of Nil Paid Rights, New Common Shares or New Depositary Interests in the United States or any jurisdiction in which the same would be unlawful. The New Common Shares, the Nil Paid Rights and the New Depositary Interests have not been and will not be registered under the U.S. Securities Act of 1933, as amended, (the "Securities Act") and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of Nil Paid Rights, New Common Shares or New Depositary Interests in the United States, the United Kingdom or elsewhere. The distribution of this announcement and the offering or sale of the Nil Paid Rights, New Common Shares or New Depositary Interests in certain jurisdictions may be restricted by law. No action has been taken by the Company, J.P. Morgan Cazenove, J.P. Morgan Securities Ltd. ("JPMSL"or UBS Limited ("UBS") that would permit an offering of such Nil Paid Rights, New Common Shares or New Depositary Interests or possession or distribution of this announcement or any other offering or publicity material relating to such Nil Paid Rights, New Common Shares or New Depositary Interests in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company, J.P. Morgan Cazenove, JPMSL and UBS to inform themselves about, and to observe, any such restrictions.

This announcement is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by J.P. Morgan Cazenove, JPMSL or UBS or by any of their respective affiliates or agents as to or in relation to, the accuracy or completeness of this announcement, or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefor is hereby expressly disclaimed.

J.P. Morgan Cazenove, which is authorised and regulated by the FSA, is acting for the Company in connection with the Rights Issue and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to clients of J.P. Morgan Cazenove nor for providing advice in relation to the Rights Issue.

JPMSL, which is authorised and regulated by the FSA, is acting for the Company in connection with the Rights Issue and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to clients of JPMSL nor for providing advice in relation to the Rights Issue.

UBS is acting for the Company in connection with the Rights Issue and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to clients of UBS nor for providing advice in relation to the Rights Issue. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDQLBLKXBBBBB
Date   Source Headline
31st May 20247:00 amPRNPerformance Fee Arrangements Update
28th May 20243:44 pmPRNHolding(s) in Company
24th May 20245:42 pmPRNIssue of Equity
13th May 202410:58 amPRNBlock Listing Application
9th May 20243:49 pmRNSQ1 2024 Quarterly Investment Report
9th May 20247:00 amPRNNet Asset Value(s)
25th Apr 20241:04 pmPRNDirector Declaration
19th Apr 20242:59 pmPRNAnnual Report and Audited Financial Statements 2023
9th Apr 20247:00 amPRNNet Asset Value(s)
7th Mar 20247:00 amPRNNet Asset Value(s)
8th Feb 20241:50 pmPRNNet Asset Value(s)
2nd Feb 20248:00 amRNSQ4 2023 Quarterly Investment Report
29th Jan 20241:31 pmPRNSilverwood Brands Plc. Loan Conversion
11th Jan 20247:00 amPRNNet Asset Value(s)
4th Jan 202410:00 amPRNDirector Declaration
27th Dec 202312:41 pmRNSPortfolio Update
8th Dec 20237:00 amPRNNet Asset Value(s)
8th Nov 20237:00 amPRNNet Asset Value(s)
9th Oct 20237:00 amPRNNet Asset Value(s)
14th Sep 20237:01 amPRNDirectorate Change
14th Sep 20237:00 amPRNInterim Report and Unaudited Condensed Consolidated Interim Financial Statements
13th Sep 20233:30 pmPRNResults of Annual General Meeting
8th Sep 20237:00 amPRNNet Asset Value(s)
21st Aug 20231:58 pmPRNDirectorate Change
16th Aug 20238:44 amPRNNotice of AGM
15th Aug 20238:39 amRNSQ2 2023 Quarterly Investment Report
10th Aug 20234:07 pmPRNTotal Voting Rights - Correction
2nd Aug 20232:43 pmPRNTotal Voting Rights
19th Jul 20237:00 amPRNFurther issue pursuant to Statutory Squeeze Out
10th Jul 20237:00 amRNSCastelnau assists Hornby in stake in Warlord Games
10th Jul 20237:00 amPRNNet Asset Value(s)
24th Mar 20239:23 amRNSForm 8.5 (EPT/RI)
15th Mar 20239:14 amRNSForm 8.5 (EPT/RI)
14th Mar 20238:32 amRNSForm 8.5 (EPT/RI)
13th Mar 20238:56 amRNSForm 8.5 (EPT/RI)
10th Mar 20238:37 amRNSForm 8.5 (EPT/RI)
9th Mar 20239:08 amRNSForm 8.5 (EPT/RI)
8th Mar 20239:01 amRNSForm 8.5 (EPT/RI)
3rd Mar 20238:32 amRNSForm 8.5 (EPT/RI)
2nd Mar 20239:02 amRNSForm 8.5 (EPT/RI)
24th Feb 20239:35 amRNSForm 8.5 (EPT/RI)
10th Feb 20239:59 amRNSForm 8.5 (EPT/RI)
6th Feb 20238:43 amRNSForm 8.5 (EPT/RI)
2nd Feb 20239:05 amRNSForm 8.5 (EPT/RI)
1st Feb 20238:34 amRNSForm 8.5 (EPT/RI)
27th Jan 20239:07 amRNSForm 8.5 (EPT/RI)
25th Jan 20238:30 amRNSForm 8.5 (EPT/RI)
18th Jan 20234:08 pmRNSForm 8.3 - Castelnau Group Limited
17th Jan 202310:59 amRNSForm 8.5 (EPT/RI)
16th Jan 202310:26 amBUSForm 8.3 - Castelnau Group Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.